Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of extraordinary shareholders’ meeting in InCoax Networks AB

The shareholders of InCoax Network AB, Reg. No. 556794-1363, are hereby invited to attend the extraordinary shareholders’ meeting to be held at the company’s premises at Utmarksvägen 4 in Gävle, on Tuesday 10 November 2020, at 12.00 p.m.The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Information regarding the coronavirus As a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of InCoax Networks AB (“InCoax”) has decided to keep

Dignitana publishes October newsletter

Dignitana AB today publishes the October 2020 newsletter highlighting the Company's recently announced selection as the scalp provider of choice by City of Hope and ION Solutions.To read the newsletter follow this link: https://mailchi.mp/dignitana/in-brief-oct2020 The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To subscribe to receive future Dignitana news directly to your email, click here .

Inhalation Sciences AB (ISAB) presents schedule regarding clinical validation of PreciseInhale

(Stockholm, 21 October 2020) Due to the COVID-19 situation, and the transition from MDD (Medical Device Directive) to MDR (Medical Device Regulation) which places greater demands on regulatory documentation, quality systems and risk management prior to clinical trials, ISAB presents its plan for the clinical validation of PreciseInhale.The COVID-19 pandemic has affected all ongoing and planned clinical trials globally. Patient recruitment has come to a complete halt during the pandemic and is expected to resume at a slow pace during the winter of 2020. In the planned clinical study, ISAB

Safety and productivity in focus as Epiroc wins large equipment order in Russia

Stockholm, Sweden: Epiroc, a leading productivity partner for the mining and infrastructure industries, has won a significant order from Norilsk Nickel for underground mining equipment that will strengthen safety while ensuring a highly efficient mine development.Norilsk Nickel is one of the world’s largest producers of nickel, palladium, platinum and copper and has a high focus on automation and new technologies. The mining company has ordered Epiroc’s Boltec M and Cabletec M rigs for use in the Oktyabrskiy, Mayak and Komsomolskiy mines in Russia to reinforce the underground rock in the

The Nomination Committee in InCoax Networks AB proposes Alf Eriksson as new board member

The Nomination Committee in InCoax Networks AB (”InCoax” or the ”Company”) has today notified the Company that it will propose Alf Eriksson as new board member for election at an Extraordinary Shareholder’s Meeting to be held on November 10, 2020. Alf Eriksson replaces Richard Tooby who previously resigned from the board of directors.Alf Eriksson brings solid experience gained from over 30 years in the telecom industry. Alf Eriksson, born 1961, has a thorough managerial experience from the telecom industry, working for world leading listed companies as well as prominent technology startups.

Nomination committee in Oncopeptides established

STOCKHOLM — October 21, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the composition of the Nomination Committee for the Annual General Meeting 2021 has been established. The Nomination Committee consists of the following persons who together represent approximately 34 percent of the number of shares and votes in the company, based on the shareholder information by the end of September;· Staffan Lindstrand, appointed by HealthCap VI L.P. · Patrik Sobocki, appointed by Stiftelsen Industrifonden · Ulrik Grönvall, appointed by Swedbank Robur Fonder ·

Ex share consolidation and subscription right in subsequent offering today

Reference is made to the stock exchange notices by Solstad Offshore ASA on 19 October 2020 on key information relating to the share consolidation (reverse split) and on 20 October 2020 on key information relating to the contemplated subsequent offering, both as approved by the extraordinary general meeting on 20 October 2020. The shares in Solstad Offshore ASA will trade exclusive the reverse share split and exclusive of the right to receive subscription rights to subscribe for shares in the subsequent offering from and including today, 21 October 2020. This information is published

INVITATION: Finnair Q3 2020 result – Press conference and analyst webcasts

Finnair will hold a Q3 financial result press conference (in Finnish) on 28 October 2020 at 11:00 a.m. EET via a live webcast: https://finnairgroup.videosync.fi/2020-1028-press  An English-language telephone conference and webcast will begin at 1:00 p.m. EET. The conference may be attended by dialling your local access number +358 (0)9 8171 0310 (Finland), 08 5664 2651 (Sweden), 033 3300 0804 (UK) or +44 (0)33 3300 0804 (all other countries). The confirmation code is 78153995#. We kindly suggest to call in 5 minutes before the conference

In Search of Brilliant Minds – Gunnebo Launches New Trainee Programme: Upskill

Upskill will target university graduates around the world and bring talents and a new way of thinking to Gunnebo. In October 2020, Gunnebo will begin to look for applicants among university graduates to take part in the newly established Upskill Trainee Programme.“We are investing in this programme now because we believe in our future – and a key part of that future is bringing new talent into the organisation. We want to recruit individuals who not only support and contribute to our business, but also have the skills to challenge us,” says Stefan Syrén, President & CEO, Gunnebo. Gunnebo

Interim report Byggmax Group January 1 - September 30

STRONG BYGGMAX IN A STRONG MARKETSUMMARY OF THE THIRD QUARTER OF 2020• Net sales increased to SEK 2,200 M (1,813), representing growth of 21.4 percent.• The Group’s currency adjusted like-for-like sales increased by 20.4 percent.• The gross margin was 33.1 percent (32.2).• EBITA amounted to SEK 335 M (220), with an EBITA margin of 15.2 percent (12.2).• EBIT amounted to SEK 325 M (210), with an EBIT margin of 14.8 percent (11.6).• Net profit for the period amounted to SEK 250 M (156).• Earnings per share totalled SEK 4.09 (2.55).• Cash flow from operating activities decreased

Eurobattery Minerals receives approximately SEK 22.7 million through warrant redemption

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. During June-July 2020, Eurobattery Minerals AB (publ) (NGM Nordic SME: "BAT"; "the Company") carried out a rights issue of units, consisting of shares and warrants of series 2020:1 (the "Warrants"). Those

Upgraded estimate of addressable market for Mangoral to $500-600 million annually

Ascelia Pharma AB (publ) (ticker: ACE) today announced that its estimate of the addressable market in the US, EU and Japan for its lead candidate drug Mangoral has been increased to $500-600 million (previously $350-500 million). Preparations for launch are progressing well, with a strong case for own commercialization in the US. Investors, analysts and media are invited to today’s virtual Capital Markets Day where Mangoral’s market opportunity and commercial preparations are in focus.Upgraded estimate of addressable market The addressable market for Ascelia Pharma’s novel contrast agent

Quarterly Report Q3 2020

Strong recovery in the quarter Third quarter · Net sales decreased by 8% to SEK 22,225 M (24,034), with organic growth of –5% (4) and acquired net growth of 4% (4) · Entrance Systems reported organic sales growth, while EMEA reported stable organic sales development. Global Technologies, Asia Pacific and Americas reported negative organic sales growth. All divisions were strongly negatively affected by Covid-19 · Sales and income for agta record are fully consolidated into the Group from 31 August 2020 · Operating income (EBIT[1])[ ]decreased by 8% to SEK 3,593 M (3,894),

MAG Interactive AB (publ) publishes Interim and Year-End Report September – August 2019/2020

Net sales grew by 28% compared to the same quarter the previous year.Summary of the period June 2020 – August 2020: · The Group's net sales for the period were 55,100 KSEK (43,109 KSEK), an increase of 28% compared to the same period the previous year · EBITDA for the period was 7,664 KSEK (5,985 KSEK) · Adjusted EBITDA for the period was -1,852 KSEK (5,985 KSEK) (adjustments relate to effects from research and development deductibles, acquisition costs and effects from IFRS16) · The Group's game contribution for the period was 25,662 KSEK (29,547 KSEK), a decrease of 13%

Viking Line: Business Review for the period January - September 2020

Viking Line Abp       BUSINESS REVIEW              21.10.2020, 9.00 AM Deterioration in Viking Line’s results due to the impact of COVID-19 January–September 2020 (compared to January–September 2019) · Sales amounted to EUR 154.2 M (380.8). · Other operating revenue was EUR 16.7 M (0.2). · Operating income totalled EUR -35.2 M (17.5). · Net financial items were EUR -3.1 M (-3.6). · Income before taxes amounted to EUR -38.3 M (13.9). · Income after taxes totalled EUR -30.8 M (11.1). · Future prospects unchanged: Income for the full financial year will be negative.

COVID-19 crisis demands actions not words from G20 anti-corruption meeting

The G20 anti-corruption ministerial meeting taking place tomorrow, 22 October, must result in concrete steps that will prevent corruption from undermining the global coronavirus response and recovery, Transparency International said today. As UN Secretary General Antonio Guterres recognised last week , the response to the virus is creating new opportunities to exploit weak oversight and inadequate transparency. Transparency International has identified over US$1 billion lost to corruption and malfeasance related to

Rottneros AB (publ) Nominating Committee and Annual General Meeting 2021

Rottneros AB (publ) (“Rottneros”) Annual General Meeting will be held on Wednesday, 28 April 2021, in Söderhamn. The Nominating Committee has been appointed.In accordance with the guidelines decided at Rottneros Annual General Meeting 2020, the Nominating Committee has been appointed for the Annual General Meeting 2021. The Nominating Committee comprises: · Julia Onstad, appointed by Arctic Paper S.A. · Stefan Sundh, appointed by PROAD AB · Per Lundeen, Chairman Rottneros AB The Nominating Committee has appointed Julia Onstad as its Chairwoman. The two owner

Interim report for January 1 – September 30, 2020

SPLIT-UP BEING FINALIZED THIRD QUARTER · Net sales amounted to SEK 460.7 (540.8) million- CDON increased external merchant’s sales by 100 percent. Net sales increased by 82 percent for CDON Marketplace (service income) and decreased by 42 percent for CDON Retail (sale of own goods).- Nelly’s sales in the Nordics decreased by 3 percent but was stable in local currencies in the Nordic. In line with the Nordic focus, sales decreased outside the region. · Operating profit before depreciation and amortization improved to SEK 14.0 (-0.8) million- CDON’s operating profit before

Odd Molly carries out a fully guaranteed rights issue of approx. SEK 110 million and directed issues of approx. SEK 135 million, acquires a portfolio with a property value of approx. SEK 354 million

Odd Molly International AB (publ) Stockholm, October 21, 2020 NOT FOR PUBLICATION, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER COUNTRY WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS OR WOULD REQUIRE ADDITIONAL DOCUMENTATION TO BE PREPARED OR REGISTERED OR REQUIRE ANY OTHER ACTION TO BE TAKEN, IN ADDITION TO THE REQUIREMENTS OF SWEDISH LAW. THIS PRESS RELEASE IS NOT A PROSPECTUS BUT A PUBLICATION ODD MOLLY'S

Swedish Stirling and ABB initiate collaboration

Swedish Stirling AB and ABB Sweden have initiated a technical collaboration regarding a unique solution for conversion of residual gases to electricity. ABB will supply components and systems for the PWR BLOK, and will assist with knowledge and expertise as well.Clean tech company Swedish Stirling and ABB have initiated a technical collaboration on the PWR BLOK. ABB will supply low-voltage products and drive for the PWR BLOK, and will contribute its skill and expertise in the field. The purpose of the collaboration is primarily to reduce production costs ahead of mass production, which

Q3 2020: Strong growth with good profitability

Significant events during the third quarter · Net sales increased by 38% (43% adjusted for currency changes) to SEK 195 m (142). Positive one-off effect of around SEK 15 m from an American customer's product update program. · The EBITDA margin was 32% (32%). · New vice president R&D recruited starting September. · New research study with Lund University published showing a link between probiotics and reduced side-effects from stress. Significant events after the end of the period · Acquisition of shares in Vital Nutrients Holdings and entering into strategic

Danish biotech UNION adds program to prevent COVID-19 with intranasal delivery of niclosamide.

· Niclosamide is a potent inhibitor of SARS-CoV-2 with potency >40x higher than remdesivir as demonstrated by Institut Pasteur Korea · The sinonasal cavity is considered a major site of early infection by SARS-CoV-2 and a major factor in transmission.  · Intranasal administration of niclosamide has been demonstrated to prevent fatal outcomes in a murine challenge model · UNI91103 is a nasal spray pump delivering a concentrated niclosamide salt solution to the nasal cavity · UNI91103 has been tested in 44 healthy volunteers with positive results · UNI91103 is being prepared for

Interim report, January–September 2020

Building for growth in 2021January–September 2020 · Revenue amounted to TSEK 126,844 (166,327). · Operating profit amounted to TSEK -28,958 (-2,247). · Operating profit excluding non-recurring costs amounted to TSEK -28,958 (10,050). · Profit after tax amounted to TSEK -48,366 (34,677). The result includes currency conversions and financial transaction costs of TSEK 22,351 (43,577). · Earnings per share amounted to SEK -1.19 (1.13). July-September 2020 · Revenue amounted to TSEK 32,285 (56,979). · Operating profit amounted to TSEK -17,000 (2,142). · Operating

Replacing fossil-based plastics with renewables – introducing Mysoda’s new sparkling water makers made of innovative UPM Formi EcoAce

(UPM, Lahti, 21[st] October 2020 at 09:00 EET) – UPM Biocomposites and Finnish Mysoda have collaborated to create a range of sparkling water makers made almost entirely out of renewable materials. Traditionally, small kitchen appliances are made out of fossil-based plastics, so this innovation takes the sustainability of this type of product to a completely new level by substantially reducing the carbon footprint of the product. [A tree in a forest Description automatically generated] The raw material used for the Mysoda sparkling water makers is UPM Formi EcoAce biocomposite, which

There are no items matching the current filter
There are no more items matching the current filter
Back to top